Groowe Groowe BETA

US Stock Market News

Stay on top of the US stock market with real-time breaking news and market-moving stories. Our platform continuously aggregates updates from trusted financial news sources, giving traders and investors a fast overview of events that may impact stock prices.

Whether you're tracking specific companies or scanning the broader market, the news feed helps you quickly identify important developments as they happen.

Create an account to access the live news feed. Access is free while the platform is in beta. Visitors without an account can still browse the latest headlines with a 15-minute delay.

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Class Action Lawsuit Filed Against FS KKR Capital Corp (FSK) – Recover Losses – Contact Levi & Korsinsky Before July 6, 2026

accessnewswire.com
FSK

Contact Levi & Korsinsky by July 28, 2026 to Join Class Action Against Lucid Group, Inc. (LCID)

accessnewswire.com
LCID

Levi & Korsinsky Notifies Phreesia, Inc. (PHR) Shareholders of Class Action Lawsuit and July 13, 2026 Deadline

accessnewswire.com
PHR

FS KKR DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages FS KKR Capital Corp. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - FSK

accessnewswire.com
FSK

Phreesia Deadline: PHR Investors with Losses in Excess of $100K Have Opportunity to Lead Phreesia, Inc. Securities Fraud Lawsuit

prnewswire.com
PHR

Concept Study Identifies Potential Refining Pathway at Shaakichiuwaanaan to Battery-Grade Lithium Carbonate

prnewswire.com
TSLA

Securities Lawsuit Alert: GeneDx Holdings Corp. (WGS) Investors - Contact Levi & Korsinsky Before August 3, 2026

accessnewswire.com
WGS

Via Transportation, Inc. (VIA) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of August 10, 2026 Deadline

accessnewswire.com
VIA

GeneDx Holdings Corp. (WGS) Class Action Lawsuit: Investors Face August 3, 2026, Deadline - Contact Kessler Topaz Meltzer & Check, LLP

prnewswire.com
WGS

Crinetics Presents Full Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH) in Oral Presentation at ENDO 2026

globenewswire.com
CRNX
View all news →